Vera Therapeutics | 10-K: Annual report

SEC16:01 ET · Announcements

TD Cowen Maintains Vera Therapeutics(VERA.US) With Buy Rating, Maintains Target Price $60

Moomoo NewsFeb 27 20:32 ET · Ratings

Guggenheim Maintains Vera Therapeutics(VERA.US) With Buy Rating, Cuts Target Price to $61

Moomoo NewsFeb 27 08:31 ET · Ratings

Vera Therapeutics to Participate in the TD Cowen 45th Annual Health Care Conference

GlobeNewswireFeb 27 08:00 ET

Express News | Vera Therapeutics Inc : Guggenheim Raises Target Price to $61 From $59

ReutersFeb 27 06:59 ET

Wells Fargo Maintains Vera Therapeutics(VERA.US) With Buy Rating, Maintains Target Price $70

Moomoo NewsFeb 27 06:31 ET · Ratings